I completely disagree. Any entrant is bad for CSS. It just adds to competitive pressures. At the end of the day you would much rather to be selling into a market with no competition than a market with competition.
The threat to CSS is domestic and international competition. Competition is inevitable but its more about response.
The early product positioning and cost containment should bode well for the company over the LT.
- Forums
- ASX - By Stock
- Recent up tick good for holders
CSS
clean seas seafood limited
Add to My Watchlist
0.00%
!
13.5¢

I completely disagree. Any entrant is bad for CSS. It just adds...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.28M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 13.5¢ | $18.51K | 137.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4127350 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 6763916 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 4127350 | 0.135 |
3 | 77222 | 0.130 |
1 | 7200 | 0.125 |
1 | 7500 | 0.120 |
1 | 7826 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 6763916 | 25 |
0.145 | 68473 | 1 |
0.150 | 7500 | 2 |
0.155 | 8000 | 1 |
0.200 | 7760 | 1 |
Last trade - 15.40pm 27/06/2025 (20 minute delay) ? |
Featured News
CSS (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online